Disodium etidronate was the first bisphosphonate to be used clinically in the management of Paget's disease.
Adverse effects include:
There have now been developed second- and third- generation bisphosphonates.
The summary of product characteristics should be consulted before prescribing this drug.
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page